RXST vs. SLNO
Compare and contrast key facts about RxSight, Inc. (RXST) and Soleno Therapeutics, Inc. (SLNO).
Scroll down to visually compare performance, riskiness, drawdowns, and other indicators and decide which better suits your portfolio: RXST or SLNO.
Performance
RXST vs. SLNO - Performance Comparison
Returns By Period
In the year-to-date period, RXST achieves a 11.14% return, which is significantly lower than SLNO's 36.22% return.
RXST
11.14%
-11.30%
-27.47%
61.77%
N/A
N/A
SLNO
36.22%
2.01%
27.90%
96.31%
18.78%
-15.48%
Fundamentals
| RXST | SLNO | |
|---|---|---|
| Market Cap | $1.82B | $2.23B |
| EPS | -$0.81 | -$2.79 |
| Total Revenue (TTM) | $138.39M | $3.45M |
| Gross Profit (TTM) | $87.81M | $1.97M |
| EBITDA (TTM) | -$30.52M | -$136.50M |
Key characteristics
| RXST | SLNO | |
|---|---|---|
| Sharpe Ratio | 1.10 | 1.63 |
| Sortino Ratio | 1.90 | 2.34 |
| Omega Ratio | 1.23 | 1.27 |
| Calmar Ratio | 1.61 | 1.00 |
| Martin Ratio | 3.82 | 7.70 |
| Ulcer Index | 15.36% | 12.48% |
| Daily Std Dev | 53.31% | 58.83% |
| Max Drawdown | -48.21% | -99.86% |
| Current Drawdown | -30.30% | -91.64% |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Correlation
The correlation between RXST and SLNO is 0.17, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.
Risk-Adjusted Performance
RXST vs. SLNO - Risk-Adjusted Performance Comparison
This table presents a comparison of risk-adjusted performance metrics for RxSight, Inc. (RXST) and Soleno Therapeutics, Inc. (SLNO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Dividends
RXST vs. SLNO - Dividend Comparison
Neither RXST nor SLNO has paid dividends to shareholders.
Drawdowns
RXST vs. SLNO - Drawdown Comparison
The maximum RXST drawdown since its inception was -48.21%, smaller than the maximum SLNO drawdown of -99.86%. Use the drawdown chart below to compare losses from any high point for RXST and SLNO. For additional features, visit the drawdowns tool.
Volatility
RXST vs. SLNO - Volatility Comparison
RxSight, Inc. (RXST) has a higher volatility of 13.75% compared to Soleno Therapeutics, Inc. (SLNO) at 11.08%. This indicates that RXST's price experiences larger fluctuations and is considered to be riskier than SLNO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Financials
RXST vs. SLNO - Financials Comparison
This section allows you to compare key financial metrics between RxSight, Inc. and Soleno Therapeutics, Inc.. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities